Seasoned Pharmaceutical Industry leader within the Clinical Development and Medical Affairs areas. Recognized as highly energetic with excellent communication skills and the ability to solve complex problems in a fast-paced global environment. Track record in launching gastrointestinal, cardiovascular and diabetes new treatments; internationally connected with a diverse network of experts in gastrointestinal disease, metabolic diseases, and cardiology. Proven ability to motivate cross-functional teams and work effectively with people from different cultures and all walks of life to benefit patients’ health.
Consulting mission
- Enhancing Medical Affair’s strategic focus
- Driving efficiency and effectiveness
- Ensuring Launch preparedness
- Creating meaningful metrics
- Establishing patient centric medical practices
- Global-regional-local Medical partnership and governance
- Establishing Medical insights processes
Therapeutic Areas of Expertise
- Upper Gastrointestinal diseases
- Diabetes & DM Nephropathy
- Atherosclerosis
- Thrombosis
- Heart Failure
- Pulmonary Arterial Hypertension
- Hypertension
- Rare diseases: lipodystrophy, Familial Chylomicron syndrome; hypoxia inductible factor- erythropoietin gene expression regulation
Therapeutic Areas of Interest
- MASH, Hypertriglyceridemia, CKD